Longwood Capital Partners »

Unicycive Therapeutics shares owned by Longwood Capital Partners

Quarter-by-quarter ownership of Unicycive Therapeutics (UNCY) shares owned by Longwood Capital Partners from 13F filings

Historical chart of Longwood Capital Partners investment in Unicycive Therapeutics

Oct 62024Oct 20Nov 3Nov 17Dec 1Dec 15Dec 291M1.5M2M2.1M2.2M2.3M
Value ($)Share countHistorical UNCY position of Longwood Capital Partners Source: stockzoa.comValue ($)Share count

Tip: Access up to 7 years of quarterly data

All positions including Unicycive Therapeutics held by Longwood Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Unicycive Therapeutics by Longwood Capital Partners

Quarter filed Position value Share count Share price at filing
2024-12-31 $1.8M 2.3M 0.79
2024-09-30 $807k 2.0M 0.41

More positions owned by Longwood Capital Partners

Ocular Therapeutix (OCUL)
Insmed Com Par $.01 (INSM)
Tourmaline Bio (TRML)
Crinetics Pharmaceuticals In (CRNX)
Enliven Therapeutics (ELVN)
Aadi Bioscience (AADI)
Praxis Precision Medicines I (PRAX)
Revolution Medicines (RVMD)
Argenx Se Sponsored Adr (ARGX)
Vaxcyte (PCVX)
Trevi Therapeutics (TRVI)
Ascendis Pha- Sponsored Adr (ASND)
Mereo Biopharma Group Pl- Spon Ads (MREO)
Bright Minds Biosciences Com New (DRUG)
Terns Pharmaceuticals (TERN)

View all positions for Longwood Capital Partners

Top funds holding Unicycive Therapeutics

Dr. Jeffrey R. Jay, M.D.
Nantahala Capital Management
Octagon Capital Advisors
Vivo Capital
Logos Global Management
Walleye Trading Advisors
Silverarc Capital Management
Longwood Capital Partners
Alyeska Investment Group
Altium Capital Management
Vanguard Group
Geode Capital Management
XTX Topco
State Street Corporation
Goldman Sachs Group

View all funds holding Unicycive Therapeutics